Literature DB >> 28675922

How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model.

James Troendle1, Eric Leifer1, Zhiwei Zhang2, Song Yang1, Heather Tewes3.   

Abstract

In an observational study of the effect of a treatment on a time-to-event outcome, a major problem is accounting for confounding because of unknown or unmeasured factors. We propose including covariates in a Cox model that can partially account for an unknown time-independent frailty that is related to starting or stopping treatment as well as the outcome of interest. These covariates capture the times at which treatment is started or stopped and so are called treatment choice (TC) covariates. Three such models are developed: first, an interval TC model that assumes a very general form for the respective hazard functions of starting treatment, stopping treatment, and the outcome of interest and second, a parametric TC model that assumes that the log hazard functions for starting treatment, stopping treatment, and the outcome event include frailty as an additive term. Finally, a hybrid TC model that combines attributes from the parametric and interval TC models. As compared with an ordinary Cox model, the TC models are shown to substantially reduce the bias of the estimated hazard ratio for treatment when data are simulated from a realistic Cox model with residual confounding due to the unobserved frailty. The simulations also indicate that the bias decreases or levels off as the sample size increases. A TC model is illustrated by analyzing the Women's Health Initiative Observational Study of hormone replacement for post-menopausal women. Published 2017. This article has been contributed to by US Government employees and their work is in the public domain in the USA. Published 2017. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  bias; frailty; hazard; matching; propensity

Mesh:

Year:  2017        PMID: 28675922      PMCID: PMC5585047          DOI: 10.1002/sim.7377

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Simulating competing risks data in survival analysis.

Authors:  Jan Beyersmann; Aurélien Latouche; Anika Buchholz; Martin Schumacher
Journal:  Stat Med       Date:  2009-03-15       Impact factor: 2.373

3.  Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Authors:  Song Yang; Ross L Prentice
Journal:  Stat Med       Date:  2015-02-17       Impact factor: 2.373

4.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

5.  Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.

Authors:  Alan S Go; Jingrong Yang; Jerry H Gurwitz; John Hsu; Kimberly Lane; Richard Platt
Journal:  Arch Intern Med       Date:  2008-12-08

6.  Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study.

Authors:  Robert W Yeh; Malini Chandra; Charles E McCulloch; Alan S Go
Journal:  BMC Med       Date:  2011-06-24       Impact factor: 8.775

7.  Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings.

Authors:  Richard L Tannen; Mark G Weiner; Dawei Xie
Journal:  BMJ       Date:  2009-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.